a new standard of care for low risk stage iii colorectal cancer?: asco 2017 update
Published 5 years ago • 553 plays • Length 10:37Download video MP4
Download video MP3
Similar videos
-
5:40
updated results from a pooled analysis of 3 v 6 months of adjuvant therapy for stage 3 colon cancer
-
1:54
standard-of-care for adjuvant treatment of colon cancer
-
1:13
dr. morris on the design of the cobra trial in stage ii colon cancer
-
3:06
6 ways to lower your risk of colon cancer
-
0:11
life of young colon cancer survivor
-
50:22
treatment options for stage iii colon cancer - june 2017 webinar
-
55:10
enhancing risk stratification in early colon cancer with tnm-i (immune) staging: focus on stage...
-
29:15
icaho20 - asco direct™ highlights - dr. axel grothey - colorectal cancer
-
16:41
can we refine the selection for adjuvant treatment in stage ii colon cancer?
-
5:23
adjuvant therapy for stage ii and iii colon cancer
-
5:16
adjuvant treatment for colon cancer: how to treat a stage iii colon cancer?
-
4:31
cobra: ctdna to help decide which patients with colon cancer will benefit from adjuvant chemotherapy
-
21:41
update 5: updates in the management of rectal cancer
-
7:42
implications of new data in colon cancer
-
4:11
adjuvant therapy for colorectal cancer
-
0:49
warning signs of colon cancer.
-
3:14
adjuvant cetuximab in the petacc8 trial for stage iii colon cancer
-
59:04
post asco webinar 2019
-
20:07
2022 west oncology conference | gastrointestinal cancers | colorectal session